Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

45.71

-5.58 (-10.88%)

At close: Nov 5, 2026, 4:00 PM EST

41.74

-3.97 (-8.69%)

Pre-market: Nov 6, 2026, 4:24 AM EST

Rigel Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	288.21	294.28	179.28	116.88	115.74	138.74
Revenue Growth	2.18%	64.15%	53.38%	0.98%	-16.57%	27.73%
Gross Profit	225.05	241.37	137.25	85.25	53.72	72.42
Operating Income	75.74	125.47	24.19	-20.49	-58.73	-19.48
Net Income	307.19	367.02	17.49	-25.09	-58.57	-17.91
Earnings Per Share	15.38	19.48	0.99	-1.44	-3.44	-1.05
EPS Growth	148.26%	1867.68%	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	99.31	154.96	77.32	56.93	58.21	124.97
Total Debt	7.79	53.3	99.95	104.17	87.75	91.27
Net Cash (Debt)	91.51	101.65	-22.63	-47.23	-29.55	33.7
Net Cash Growth	20.00%	-	-	-	-	84.77%
Net Cash Per Share	4.58	5.40	-1.28	-2.71	-1.73	1.98

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	89.92	75.66	31.47	-5.74	-73.76	5.88
Capital Expenditures	0.01	-	-0.04	-	-0.45	-0.63
Free Cash Flow	89.93	75.66	31.44	-5.74	-74.21	5.25
Free Cash Flow Growth	31.98%	140.67%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	78.08%	82.02%	76.56%	72.94%	46.41%	52.20%
Operating Margin	26.28%	42.63%	13.49%	-17.53%	-50.74%	-14.04%
Pretax Margin	26.15%	41.40%	10.24%	-21.47%	-50.61%	-12.48%
Profit Margin	106.59%	124.72%	9.75%	-21.47%	-50.61%	-12.91%
FCF Margin	31.20%	25.71%	17.53%	-4.91%	-64.11%	3.79%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.97	2.12	16.95	-	-	-
Forward PE	13.54	10.49	17.39	-	-	-
P/FCF Ratio	9.49	10.28	9.43	-	-	86.30
PS Ratio	2.96	2.64	1.65	2.16	2.24	3.27